ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

A Winning Playbook for Pain: Tackle Surgery with Non-Opioid Therapies

photo

SPONSORED CONTENT -- (StatePoint) As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to tackle post-surgical pain can mark the difference between a challenging or seamless recovery. However, it was her own experience with surgery after a cycling accident in 2016 that led her to rethink her approach to pain management.

During her procedure, Dr. West’s surgeon administered a non-opioid pain therapy, EXPAREL (bupivacaine liposome injectable suspension), as part of a multimodal pain management approach, which led to minimal pain and the ability to completely forgo the use of opioids during her recovery.

“It was a total game-changer for me to experience firsthand how effective pain management can provide an enhanced recovery process,” said Dr. West. “In my work with athletes, I recognize that recovery can’t wait, as my patients are eager to get back to their active lifestyles. Understanding that there are non-opioid therapies available that can effectively manage pain and allow for a quicker recovery encouraged me to modify my surgical protocols.”

Sending Opioids to the Sidelines

EXPAREL is a non-opioid pain relief shot given during surgery that lasts for the first few days after a procedure that can reduce – or even eliminate – the need for opioids. In recent years, healthcare professionals have recognized that opioids are often accompanied by negative side effects, such as nausea, dizziness or drowsiness, that can actually hinder the recovery process. The shift toward a multimodal approach, including non-opioid pain therapies like EXPAREL, has empowered surgeons to develop individualized pain management plans that meet the needs of their patients.

Dr. West’s refined approach to pain relief has been underscored by her patients’ experiences receiving EXPAREL. Brandon Chubb, a former NFL linebacker, co-founder of the Chubb Foundation, and player director of the NFL Players Association, underwent multiple knee surgeries throughout his athletic career. It wasn’t until Dr. West performed his revision ACL surgery in 2022 that he discovered the benefits of non-opioid pain therapies. 

“The pain after my earlier surgeries was unbearable, and the opioids I was prescribed came with a slew of side effects that made my recovery more challenging,” Chubb said. “When Dr. West introduced me to EXPAREL during my last ACL procedure, it was a completely different experience. I had no pain, no need for prescription pain medication, and I was able to focus on physical therapy and my recovery goals almost immediately.”

“Managing pain effectively is more than a comfort measure, it’s a cornerstone of recovery,” added Dr. West. “Watching my patients like Brandon regain mobility and return to the activities they love more quickly – whether that’s playing a sport, walking their dog, or completing everyday activities more comfortably – is what fuels my commitment to educating patients and other healthcare providers about non-opioid pain therapies like EXPAREL.”

How to Champion Your Own Recovery

EXPAREL isn’t just for athletes facing sports-related injuries. It’s used in a wide range of surgeries, from C-sections to cosmetic procedures and wisdom tooth removal. Studies have shown that patients who receive EXPAREL often report improved pain relief and quicker returns to their daily activities.

“Among patients, parents and caregivers, I regularly hear concerns about the surgical process and what recovery may look like, which is why it’s so important for them to understand their options and have an open dialogue around pain relief with their healthcare provider,” said Dr. West. “I encourage all patients to champion their recovery by asking their doctor about the benefits of non-opioid pain therapies.”

For more information, visit EXPAREL.com.

This article is sponsored by Pacira BioSciences, Inc.

Indication

EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.

Important Safety Information 

EXPAREL should not be used in obstetrical paracervical block anesthesia.

In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting.

In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, headache, and constipation.

In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat.

EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days.

EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women.

Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.

EXPAREL should not be injected into the spine, joints, or veins.

The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.

Full Prescribing Information is available at www.EXPAREL.com/patient.

For more information, please visit www.EXPAREL.com/patient or call 1-855-793-9727.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.      

PP-EX-US-9832              1/25

Photo Credit: (c) Jacob Wackerhausen / iStock via Getty Images Plus

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.